The roles of midbrain and diencephalic dopamine cell groups in the regulation of cataplexy in narcoleptic Dobermans

Neurobiology of Disease

Volumn 16, Issue 1, 2004, Pages 274-282

  Okura, Mutsumi ^a,b   Fujiki, Nobuhiro ^a,c   Kita, Ichiro ^a   Honda, Kazuki ^a,d   Yoshida, Yasushi ^a   Mignot, Emmanuel ^a   Nishino, Seiji ^a,e  

^a STANFORD UNIVERSITY   (United States)

^b Osaka Kaisei Hospital   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A11; Autoreceptor; Cataplexy; Diencephalic dopaminergic system; Dopamine; Narcolepsy; Periodic limb movements during sleep; REM sleep

Indexed keywords

DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATAPLEXY; CONTROLLED STUDY; DIENCEPHALON; DOG; DOPAMINERGIC NERVE CELL; DRUG EFFECT; GENE MUTATION; GRAY MATTER; MESENCEPHALON; NARCOLEPSY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD MOTONEURON; SPINAL CORD VENTRAL HORN; TEGMENTUM; THALAMUS;

ANIMALS; CATAPLEXY; DIENCEPHALON; DOGS; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENCEPHALON; NARCOLEPSY;

EID: 2342477263     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.02.008     Document Type: Article

References (49)

1. Allen R.P., Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J. Clin. Neurophysiol. 18:2001;128-147
2. Aston-Jones G., Bloom F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1:1981;876-886
3. Bjöklund A., Lindvall O. Dopamine-containing systems in the CNS. Bjöklund A., Höfelt T. Handbook of Chemical Neuroanatomy, Vol. 2, Classical Transmitter in the CNS, Part I. 1984;55-121 Elsevier, Amsterdam
4. Cedarbaum J.M., Aghajanian G.K. Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur. J. Pharmacol. 44:1977;375-385
5. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451
6. Deutch A.Y., Goldstein M., Roth R.H. Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area. Brain Res. 363:1985;307-314
7. Elam M., Clark D., Svensson T.H. Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat. Neuropharmacology. 25:1986;1003-1008
8. Fung S.J., Manzoni D., Chan J.Y.H., Pomeiano O., Barnes C.D. Locus coeruleus control of spinal motor output. Barnes C.D., Pompeiano O. Progress in Brain Research. 1991;Elsevier, Amsterdam
9. Gerin C., Privat A. Direct evidence for the link between monoaminergic descending pathways and motor activity: II. A study with microdialysis probes implanted in the ventral horn of the spinal cord. Brain Res. 794:1998;169-173
10. Gerin C., Becquet D., Privat A. Direct evidence for the link between monoaminergic descending pathways and motor activity: I. A study with microdialysis probes implanted in the ventral funiculus of the spinal cord. Brain Res. 704:1995;191-201
11. Guilleminault C., Wilson R.A., Dement W.C. A study on cataplexy. Arch. Neurol. 31:1974;255-261
12. Honda K., Riehl J., Mignot E., Nishino S. Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep. NeuroReport. 10:1999;3717-3724
13. Kanbayashi T., Honda K., Kodama T., Mignot E., Nishino S. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy. Neuroscience. 99:2000;651-659
14. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J. Neurosci. 23:2003;7-11
15. Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson's disease. Clin. Neuropharmacol. 11:1988;512-519
16. Lim R.K.S., Liu C.-N., Moffitt R.L. A Stereotaxic Atlas of the Dog's Brain. 1960;Thomas Books, Springfield, IL
17. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376
18. Lu J., Xu M., Saper C.B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray (PAG). Sleep. 25:2002;A290
19. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435:2001;6-25
20. Mignot E., Lammers G.J., Ripley B., Okun M., Nevsimalova S., Overeem S., Vankova J., Black J., Harsh J., Bassetti C., Schrader H., Nishino S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 59:2002;1553-1562
21. Miller J.D., Farber J., Gatz P., Roffwarg H., German D.C. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res. 273:1983;133-141
22. Nishino S., Arrigoni J., Valtier D., Miller J.D., Guilleminault C., Dement W.C., Mignot E. Dopamine D2 mechanisms in canine narcolepsy. J. Neurosci. 11:1991;2666-2671
23. Nishino S., Tafti M., Reid M.S., Shelton J., Siegel J.M., Dement W.C., Mignot E. Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy. J. Neurosci. 15:1995;4806-4814
24. Nishino S., Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol. 52:1997;27-78
25. Nishino S., Riehl J., Mignot E. Effects of dopaminergic and noradrenergic uptake inhibitors on dopaminergic D3 agonist-included cataplexy. Sleep. 21:1998;181
26. Nishino S., Mao J., Sampathkumaran R., Shelton J., Mignot E. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res. Online. 1:1998;49-61. (http://www.sro.org/1998/Nishino/1949/)
27. Nishino S., Riehl J., Mignot E. Effects of dopaminergic and noradrenergic uptake inhibitors on dopaminergic D3 agonist-included cataplexy. Sleep. 21:1998;181. (APSS abstract)
28. Nishino S., Okura M., Mignot M. Narcolepsy: genetic predisposition and neuropharmacological mechanisms. Sleep Med. Rev. 4:2000;57-99
29. Nishino S., Riehl J., Hong J., Kwan M., Reid M., Mignot E. Is narcolepsy REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans. Neurosci. Res. 38:2000;437-446
30. Nishino S., Ripley B., Overeem S., Nevsimalova S., Lammers G.J., Vankova J., Okun M., Rogers W., Brooks S., Mignot E. Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 50:2001;381-388
31. Okura M., Riehl J., Mignot E., Nishino S. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy. Neuropsychopharmacology. 23:2000;528-538
32. Okura M., Fujiki N., Ripley B., Takahashi S., Amitai N., Mignot E., Nishino S. Narcoleptic canines display periodic leg movements during sleep. Psychiatry Clin. Neurosci. 55:2001;243-244
33. Ornstein K., Milon H., McRae-Degueurce A., Alvarez C., Berger B., Wüzner H.P. Biochemical and radioautographic evidence for dopaminergic afferents of the locus coeruleus originating in the ventral tegmental area. J. Neural Transm. 70:1987;183-191
34. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015
35. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., Nevsimalova S., Aldrich M., Reynolds D., Albin R., Li R., Hungs M., Pedrazzoli M., Padigaru M., Kucherlapati M., Fan J., Maki R., Lammers G.J., Bouras C., Kucherlapati R., Nishino S., Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6:2000;991-997
36. Reid M.S., Tafti M., Nishino S., Sampathkumaran R., Siegel J.M., Dement W.C., Mignot E. Local administration of dopaminergic drugs into the ventral tegmental area modulate cataplexy in the narcoleptic canine. Brain Res. 733:1996;83-100
37. Ripley B., Fujiki N., Okura M., Mignot E., Nishino S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol. Dis. 8:2001;525-534
38. Shirouzu M., Anraku T., Iwashita Y., Yoshida M. A new dopaminergic terminal plexus in the ventral horn of the rat spinal cord. Immunohistochemical studies at the light and electron microscopic levels. Experientia. 46:1990;201-204
39. Skagerberg G., Lindvall O. Organization of diencephalic dopamine neurons projecting to the spinal cord in the rat. Brain Res. 342:1985;340-351
40. Steinfels G.F., Heym J., Streckjer R.E., Jacobs B.J. Behavioral correlates of dopaminergic activity in freely moving cats. Brain Res. 258:1983;217-228
41. Steininger T.L., Alam M.N., Gong H., Szymusiak R., McGinty D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res. 840:1999;138-147
42. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:1982;312-353
43. Tandberg E., Larsen J.P., Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov. Disord. 13:1998;895-899
44. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., Cornford M., Siegel J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 27:2000;469-474
45. Trulson M.E., Jacobs B.L. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res. 163:1979;135-150
46. Weil-Fugazza J., Godefroy F. Dorsal and ventral dopaminergic innervation of the spinal cord: functional implications. Brain Res. Bull. 30:1993;319-324
47. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J. Neurosci. 21:2001;1787-1794
48. Wittig R., Zorick F., Piccione P., Sicklesteel J., Roth T. Narcolepsy and disturbed nocturnal sleep. Clin. Electroencephalogr. 14:1983;130-134
49. Wu M.F., Gulyani S.A., Yau E., Mignot E., Phan B., Siegel J.M. Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience. 91:1999;1389-1399